However, after the market closed on Tuesday, the robotic surgical systems maker reported second-quarter results that well-exceeded analysts' consensus estimates -- which might make its stock harder to keep ignoring.The company also announced that in the fourth quarter, it will begin selling certain Da Vinci X and Xi disposable instruments with longer lives -- 12 to 18 uses rather than the current standard of 10.